Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells in Vivo: A Physiological Glucocorticoids-and Nrf2-Dependent Mechanism

Antioxidants and Redox Signaling

Volumn 24, Issue 17, 2016, Pages 974-990

  Benlloch, Maria ^a   Obrador, Elena ^b   Valles, Soraya L ^b   Rodriguez, Maria L ^b   Sirerol, J Antoni ^b   Alcacer, Javier ^c   Pellicer, Jose A ^b   Salvador, Rosario ^b   Cerda, Concha ^d   Saez, Guillermo T ^b,d   Estrela, Jose M ^b  

^a UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c Pathology Laboratory Quirón Hospital   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTERONE; CORTICOTROPIN; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE 1; GLUCOCORTICOID RECEPTOR; PTEROSTILBENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ANTIOXIDANT; GLUCOCORTICOID; NFE2L2 PROTEIN, HUMAN; STILBENE DERIVATIVE;

ACTH SECRETING CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CASE REPORT; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; METABOLISM; NUDE MOUSE; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOIDS; HUMANS; MELANOMA; MICE, NUDE; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84975048623     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2015.6437     Document Type: Article

References (74)

1. Adachi N, Tomonaga S, Tachibana T, Denbow DM, Furuse M. (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531: 171-175, 2006.
2. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
3. Akerboom TP, Gartner M, Sies H. Cellular hydroperoxide metabolism: the roles of glutathione peroxidases and of catalase in liver. Bull Eur Physiopathol Respir 17 Suppl: 221-227, 1981.
4. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela JM. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387-398, 2002.
5. Asensi M, Ortega A, Mena S, Feddi F, Estrela JM. Natural polyphenols in cancer therapy. Crit Rev Clin Lab Sci 48: 197-216, 2011.
6. Asensi M, Sastre J, Pallardo FV, Garcia de la Asuncion J, Estrela JM, Vina J. A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 217: 323-328, 1994.
7. Azzolini M, La Spina M, Mattarei A, Paradisi C, Zoratti M, Biasutto L. Pharmacokinetics and tissue distribution of pterostilbene in the rat. Mol Nutr Food Res 58: 2122-2132, 2014.
8. Bekasi S and Zalatnai A. Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study. Pathol Oncol Res 15: 561-566, 2009.
9. Benlloch M, Mena S, Ferrer P, Obrador E, Asensi M, Pellicer JA, Carretero J, Ortega A, Estrela JM. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J Biol Chem 281: 69-79, 2006.
10. Bergland RM and Page RB. Pituitary-brain vascular relations: a new paradigm. Science 204: 18-24, 1979.
11. Berry MN and Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43: 506-520, 1969.
12. Cai L, Li R, Wu QQ, Wu TN. [Effect of hesperidin on behavior and HPA axis of rat model of chronic stressinduced depression]. Zhongguo Zhong Yao Za Zhi 38: 229-233, 2013.
13. Chalkiadaki A and Guarente L. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer 15: 608-624, 2015.
14. Cheng TC, Lai CS, Chung MC, Kalyanam N, Majeed M, Ho CT, Ho YS, Pan MH. Potent anti-cancer effect of 3¢-hydroxypterostilbene in human colon xenograft tumors. PLoS One 9: e111814, 2014.
15. Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39: 425-435, 2010.
16. Dobos J, Kenessey I, Timar J, Ladanyi A. Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells. Pathol Oncol Res 17: 729-734, 2011.
17. Dumay A, Rincheval V, Trotot P, Mignotte B, Vayssiere JL. The superoxide dismutase inhibitor diethyldithiocarbamate has antagonistic effects on apoptosis by triggering both cytochrome c release and caspase inhibition. Free Radic Biol Med 40: 1377-1390, 2006.
18. Estrela JM, Hernandez R, Terradez P, Asensi M, Puertes IR, Vina J. Regulation of glutathione metabolism in Ehrlich ascites tumour cells. Biochem J 286 (Pt 1): 257-262, 1992.
19. Estrela JM, Obrador E, Navarro J, Lasso De la Vega MC, Pellicer JA. Elimination of Ehrlich tumours by ATPinduced growth inhibition, glutathione depletion and Xrays. Nat Med 1: 84-88, 1995.
20. Estrela JM, Ortega A, Obrador E. Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181, 2006.
21. Fauci AS. Mechanisms of the immunosuppressive and antiinflammatory effects of glucocorticosteroids. J Immunopharmacol 1: 1-25, 1978.
22. Ferrer P, Asensi M, Priego S, Benlloch M, Mena S, Ortega A, Obrador E, Esteve JM, Estrela JM. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. J Biol Chem 282: 2880-2890, 2007.
23. Ferrer P, Asensi M, Segarra R, Ortega A, Benlloch M, Obrador E, Varea MT, Asensio G, Jorda L, Estrela JM. Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia 7: 37-47, 2005.
24. Flohe L and Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 105: 114-121, 1984.
25. Flohe L and Otting F. Superoxide dismutase assays. Methods Enzymol 105: 93-104, 1984.
26. Fukuda Y, Kageyama K, Nigawara T, Kasagi Y, Suda T. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRHdeficient mice. Neurosci Lett 367: 201-204, 2004.
27. Gonzalez-Vallinas M, Gonzalez-Castejon M, Rodriguez-Casado A, Ramirez de Molina A. Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev 71: 585-599, 2013.
28. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12: 931-947, 2013.
29. Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)-cystine transporter: a new action for an old drug. Leukemia 15: 1633-1640, 2001.
30. Gumireddy K, Li A, Cao L, Yan J, Liu L, Xu X, Pazoles C, Huang Q. NOV-002, a glutathione disulfide mimetic, suppresses tumor cell invasion and metastasis. J Carcinog Mutagen 2013: pii-S7-002, 2013.
31. Harmon JM and Thompson EB. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7. Mol Cell Biol 1: 512-521, 1981.
32. Hoff JB, Dysko R, Kurachi S, Kurachi K. Technique for performance and evaluation of parapharyngeal hypophysectomy in mice. J Am Assoc Lab Anim Sci 45: 57-62, 2006.
33. Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, Kikuchi N, Satoh H, Sakamoto T, Hizawa N, Itoh K, Yamamoto M. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 15: 3423-3432, 2009.
34. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407: 390-395, 2000.
35. Javvadi P, Hertan L, Kosoff R, Datta T, Kolev J, Mick R, Tuttle SW, Koumenis C. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res 70: 1941-1950, 2010.
36. Kawabata K, Kawai Y, Terao J. Suppressive effect of quercetin on acute stress-induced hypothalamic-pituitaryadrenal axis response in Wistar rats. J Nutr Biochem 21: 374-380, 2010.
37. Kawai Y, Garduno L, Theodore M, Yang J, Arinze IJ. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J Biol Chem 286: 7629-7640, 2011.
38. Khushnud T and Mousa SA. Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer. Mol Biotechnol 55: 78-86, 2013.
39. Kroon PA, Clifford MN, Crozier A, Day AJ, Donovan JL, Manach C, Williamson G. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 80: 15-21, 2004.
40. Lachize S, Apostolakis EM, van der Laan S, Tijssen AM, Xu J, de Kloet ER, Meijer OC. Steroid receptor coactivator-1 is necessary for regulation of corticotropinreleasing hormone by chronic stress and glucocorticoids. Proc Natl Acad Sci USA 106: 8038-8042, 2009.
41. Li K, Dias SJ, Rimando AM, Dhar S, Mizuno CS, Penman AD, Lewin JR, Levenson AS. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS One 8: e57542, 2013.
42. Lin LC, Wang MN, Tseng TY, Sung JS, Tsai TH. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 55: 1517-1524, 2007.
43. Masuelli L, Di Stefano E, Fantini M, Mattera R, Benvenuto M, Marzocchella L, Sacchetti P, Focaccetti C, Bernardini R, Tresoldi I, Izzi V, Mattei M, Frajese GV, Lista F, Modesti A, Bei R. Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. Oncotarget 5: 10745-10762, 2014.
44. Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Petschen I, Brown BD, Estrela JM. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin Cancer Res 13: 2658-2666, 2007.
45. Mena S, Rodriguez ML, Ortega A, Priego S, Obrador E, Asensi M, Petschen I, Cerda M, Brown BD, Estrela JM. Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, mcl-1. J Transl Med 10: 8, 2012.
46. Mena S, Rodriguez ML, Ponsoda X, Estrela JM, Jaattela M, Ortega AL. Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism. PLoS One 7: e44524, 2012.
47. Min KJ, Jang JH, Lee JT, Choi KS, Kwon TK. Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2. J Mol Med (Berl) 90: 309-319, 2012.
48. Newsholme P, Gordon S, Newsholme EA. Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J 242: 631-636, 1987.
49. Obrador E, Benlloch M, Pellicer JA, Asensi M, Estrela JM. Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanomabearing mice. J Biol Chem 286: 15716-15727, 2011.
50. Obrador E, Carretero J, Ortega A, Medina I, Rodilla V, Pellicer JA, Estrela JM. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 35: 74-81, 2002.
51. Obrador E, Valles SL, Benlloch M, Sirerol JA, Pellicer JA, Alcacer J, Coronado JA, Estrela JM. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: an endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. PLoS One 9: e96466, 2014.
52. Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers (Basel) 3: 1285-1310, 2011.
53. Pan C, Hu Y, Li J, Wang Z, Huang J, Zhang S, Ding L. Estrogen receptor-alpha36 is involved in pterostilbeneinduced apoptosis and anti-proliferation in in vitro and in vivo breast cancer. PLoS One 9: e104459, 2014.
54. Patel KR,readi C, Britton RG, Horner-Glister E, Karmokar A, Sale S, Brown VA, Brenner DE, Singh R, Steward WP, Gescher AJ, Brown K. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci Transl Med 5: 205ra133, 2013.
55. Powell ND, Tarr AJ, Sheridan JF. Psychosocial stress and inflammation in cancer. Brain Behav Immun 30 Suppl: S41-S47, 2013.
56. Priego S, Feddi F, Ferrer P, Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Estrela JM. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2-and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther 7: 3330-3342, 2008.
57. Qi Z, Whitt I, Mehta A, Jin J, Zhao M, Harris RC, Fogo AB, Breyer MD. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 286: F590-F596, 2004.
58. Quideau S, Deffieux D, Douat-Casassus C, Pouysegu L. Plant polyphenols: chemical properties, biological activities, synthesis. Angew Chem Int Ed Engl 50: 586-621, 2011.
59. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, cancer. Lancet Oncol 5: 617-625, 2004.
60. Schlossmacher G, Stevens A, White A. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J Endocrinol 211: 17-25, 2011.
61. Shankar S, Marsh L, Srivastava RK. EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin. Mol Cell Biochem 372: 83-94, 2013.
62. Shtivelman E, Davies MQ, Hwu P, Yang J, Lotem M, Oren M, Flaherty KT, Fisher DE. Pathways and therapeutic targets in melanoma. Oncotarget 5: 1701-1752, 2014.
63. Suzuki T and Yamamoto M. Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 88: 93-100, 2015.
64. Szatrowski TP and Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
65. Thornton AM. Fractionation of T and B cells using magnetic beads. Curr Protoc Immunol Chapter 3: Unit 3 5A, 2003.
66. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by betaphenylethyl isothiocyanate. Cancer Cell 10: 241-252, 2006.
67. Valles SL, Benlloch M, Rodriguez ML, Mena S, Pellicer JA, Asensi M, Obrador E, Estrela JM. Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6-and glutathione-dependent mechanism. J Transl Med 11: 72, 2013.
68. Veenema AH, Reber SO, Selch S, Obermeier F, Neumann ID. Early life stress enhances the vulnerability to chronic psychosocial stress and experimental colitis in adult mice. Endocrinology 149: 2727-2736, 2008.
69. Vijaya Saradhi UV, Ling Y, Wang J, Chiu M, Schwartz EB, Fuchs JR, Chan KK, Liu Z. A liquid chromatography-tandem mass spectrometric method for quantification of curcuminoids in cell medium and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 878: 3045-3051, 2010.
70. Volden PA and Conzen SD. The influence of glucocorticoid signaling on tumor progression. Brain Behav Immun 30 Suppl: S26-S31, 2013.
71. Webster BR, Lu Z, Sack MN, Scott I. The role of sirtuins in modulating redox stressors. Free Radic Biol Med 52: 281-290, 2012.
72. Wind S, Beuerlein K, Eucker T, Muller H, Scheurer P, Armitage ME, Ho H, Schmidt HH, Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 161: 885-898, 2010.
73. Xu Y, Ku B, Tie L, Yao H, Jiang W, Ma X, Li X. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 1122: 56-64, 2006.
74. Zhang N, Lin JK, Chen J, Liu XF, Liu JL, Luo HS, Li YQ, Cui S. MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating proopiomelanocortin (POMC) expression by targeting mitogenactivated protein kinase 8.JBiolChem288: 10361-10373, 2013.